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Abstract
Background: Congenital B cell lymphocytosis is a rare clinical syndrome.
Recently, two activating germ line mutations in CARD11 have been iden-
tiﬁed as driving disease in patients with what we now refer to as BENTA (B
cell Expansionwith NF-kB and Tcell Anergy). Herewe report a new patient
with BENTA disease who was found to have a heterozygous, germ line de
novo G123D CARD11 mutation.
Case report: 1 year male presented with fever, loose motion since &
respiratory distress 1month. He has history of NICU stays for respiratory
distress for 20 days. On examination signiﬁcant lymphadenopathy with
hepato-spleenomegaly. Investigation: - CBC s/o of Bicytopenia in form of
HB 4.3 gm. % & PLT 72000 with lymphocytosis TLC 26.3, 36%poly, 48%
lypmho, & high retic. P/S:-NCNC anemia, lymphocytosis (atypical),
decreased PLT. Renal and liver function test and LDH (244) & Uric acid
(2.6) within normal limits. Chest x ray s/o B/L minimal pleural effusion.
Bone marrow aspiration s/o absent megakaryocytes, few myeloid cells &
blast like cells present. Treatment given: ventilator support with blood
products and IV antibiotics. After 15 days of hospital stay: worsening of
bicytopenia with same size organomegaly with symptomatic
improvement.
On further Ix CMV& EBV PCR negative. CT Thorax: areas of consolidation in
B/L lung parenchyma of infective etiology. Repeat BMA with FLOW
Cytometry negative for malignancy.BM biopsy s/o normo cellular marrow
with normal trilineage cells. Majority of lymphoid cells are B cells, (CD 20,
CD 79& focally CD 10: positive). Cd 34 & Tdt is Negative.
Considering differential of autoimmune lympho-proliferative disease
(ALPS): -DCT positive, LSSA s/o B cell high- CD19+ 70% with normal T cell&
NKcells. Immunoglobulin level: - high IgG with normal IgA IgM. DNT
(double negative T cell) was negative 3%.
For rare causes of ALPS with B cell lymphocytosis: Perforin, CARD 11 and
Fas ligand was sent. Patient CARD 11 G123D germ line mutation was
present. Hence patient labeled as BENTA disease and started on siroli-
mus. Patient responded well in form of recovery from cytopenia and
resolving organomegaly. No episode of respiratory disease after starting
treatment.
Discussion: A novel congenital B cell-speciﬁc lymph proliferative disorder
termed B cell Expansion with NF-kB and T cell Anergy (BENTA) disease
characterized by excessive B cell lymphocytosis presenting in early child-
hood, with associated splenomegaly and lymphadenopathy. BENTA dis-
ease is genetically deﬁned by germ line-encoded, heterozygous GOF
mutations in CARD11. CARD11 is expressed primarily in lymphocytes and
functions as a scaffold molecule that bridges engagement of the antigen
receptor. Phenotyping reveals accumulation of both immature transitional
and mature naïve polyclonal B cells, while T cell fall within normal pedi-
atric ranges. BENTA patients exhibit several hallmarks of primary immu-
nodeﬁciencywith Sino pulmonary and ear infections other “opportunistic”
viral infections with insufﬁcient humeral immune responses in response
to polysaccharide-based vaccines.
Conclusion: BENTA disease represents different spectrum of ALPS disorder
with similar presentation but different molecular mechanism and lack of
typical feature of autoimmune phenomenon. Also traditional test DNT not
useful for a diagnosis of BENTA disease hence to diagnose such a disease
precise molecular tests are require if clinical background ﬁrmly suggestive
of disease.
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HYPER IGD SYNDROME: A CASE REPORT
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Background: Hyper IgD syndrome (HIDS) is a rare autosomal recessive
inﬂammatory genetic disorder characterized by periodic attacks of fever
associated with joint pain, skin rash and abdominal pain. It is caused by
inherited mutations in Mevalonate kinase gene that leads to decreased
activity of the enzyme mevalonate kinase (MVK)1. Patients have MVK
enzymes with reduced but not abolished activity. The prevalence is un-
known but the estimated incidence is around 200 patients worldwide.
Objective: To describe Clinical and Laboratory features of a case of Hyper
IgD syndrome
Methodology: Case study at a Tertiary care centre, Mumbai
Case: 11 months male infant 2nd BO, BONCM, brought with complaints of
fever since day 15 of life, recurring every 8-15 days, lasting for 3-4 days in
each episode. Fever is associated with skin rash which is maculopapular,
generalized and decreases when fever subsides. Fever is also associated
with cough and enlargement of cervical lymph nodes. Lymph nodes would
regress to normalcy once the fever subsided. Child had episodes of
recurrent anal abscess with fever (at 3 months), 3 episodes of dactylitis (at
5 months) and 1 episode of pneumonia. Birth and developmental history is
insigniﬁcant. No signiﬁcant family history was observed. Child was treated
symptomatically with paracetamol during attacks. On examination, child
had erythematous skin rash and cervical lymphadenopathy. Systemic ex-
amination revealed no abnormality. Child was primarily investigated for
immunodeﬁciency disease. Investigations revealed high leukocyte count
with elevated ESR. Serum IgA levels were normal. Blood sample sent to
Maryland for immunodeﬁciencywork upwas positive for Hyper IgDwith a
novel pathogenic mutation in MVK gene (1097A>G, D366G homozygous).
Patient is currently under follow up with acute episode being treated with
paracetamol, steroids and planned for Anakinra.
Discussion: HIDS is caused by genetic mutation of MVK gene. This mu-
tation is uncommon and most patients are Caucasians living in western
European countries. It begins in ﬁrst year of life with bouts of fever lasting
for 3-7 days. HIDS may be associated with diffuse skin rash, joint pain,
petechie, purpura and enlarged cervical lymph nodes. During the symp-
tom ﬂares child is non infectious and the ﬂares taper within a few days.
One of the differentials is Cryopyrin associated periodic syndrome (CAPS)
which has longer duration of ﬂares. HIDS patients have attacks throughout
life with the greatest frequency being in childhood and adolescence.
Conclusion: Hyper IgD syndrome should be suspected in a child with early
onset “attacks” of fever associated with skin rash and lymphadenopathy.
With increased inﬂammatorymarkers (raised ESR and CRP) during ﬂares, a
raised IgD levels (N <100 IU/ml) is helpful in diagnosis. Various anti
cytokine treatment modalities are available (Anakinra, Etanercet, Anti-TNF
agents2, lenalidomide, NSAIDS), the efﬁcacy of whom has not been
completely established.
PID_ALP_ID-1_V1.3
CHRONIC GRANULOMATOUS DISEASE: CASE SERIES
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Abstract
Summary: There is a paucity of data on CGD from developing countries.
We aim to study the clinical proﬁle, microbiological spectrum, treatment
approach and response in children diagnosed with CGD in a tertiary care
hospital over a span of 9 years.
Introduction: Chronic granulomatous disease (CGD) is a rare inherited
immunodeﬁciency disorder with an incidence of 4-5 per 1 million in-
dividuals; it is caused by 4 genes, 1 X-linked and 3 autosomal recessive in
